Heart Failure

In a recent study, researchers evaluated the burden of left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFpEF) in systemic sclerosis (SSc) and determined the...

A recent study conducted by researchers found a possible association between menopause before 40 years of age and heart issues.

The US FDA has approved a new treatment for a rare heart condition in certain patient populations but has restricted access.

The AHA, ACC, and HSFA have updated their joint guidelines on the treatment and management of heart failure.

The US Food and Drug Administration has approved a treatment option for adults with heart failure.

New guidelines on the management of acute and chronic heart failure have been published by the European Society of Cardiology.

A recent study aimed to examine whether an early palliative care telehealth intervention results in a better quality of life over usual care for patients with heart failure.

It is the first sodium-glucose co-transporter 2 inhibitor to be approved to treat adults with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction.

Based on its oral bioavailability and half-life, torsemide may appear to be a more efficient diuretic than furosemide, but authors of a new study wanted to shed more light on the medications’ clinical...

Authors of a new study presented at the AHA Scientific Sessions 2019 sought to determine whether cardiac biomarkers could identify patients at higher baseline risk for cardiovascular mortality or heart...